Tag Archives: American Society of Clinical Oncology

January, 2018

31 January
CAR T-Cell Immunotherapy Named Advance of the Year in Annual ASCO Report

ALEXANDRIA, VA — A new and unique new way to treat cancer – CAR T-cell therapy – is poised to transform the outlook for children and adults with certain otherwise incurable cancers. The American Society of Clinical Oncology (ASCO) named this type of adoptive cell immunotherapy the Advance of the Year …
Share

5 June
Juno Therapeutics Presents Updated Results for its CAR-T Candidate in Aggressive NHL

SEATTLE–(BUSINESS WIRE)–Juno Therapeutics, Inc. (NASDAQ: JUNO), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today announced updated data from the TRANSCEND trial of JCAR017 in relapsed and refractory (r/r) aggressive B cell non-Hodgkin lymphoma (NHL) in a presentation at the 2017 Annual Meeting of the American …
Share
5 June
ASCO 2017: Ovarian Cancer Drug Delivers ‘Very Promising’ Results in Early Trial

A new targeted treatment for ovarian cancer has shown ‘very promising’ results in an early clinical trial – shrinking tumors in half of women with the disease. Researchers believe the drug, which mimics the action of folic acid to enter cells, could hold huge promise for women with advanced ovarian …
Share

20 March
First Global Guidance for HPV Vaccination for Cervical Cancer Prevention

ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today issued a clinical practice guideline on human papillomavirus (HPV) vaccination for the prevention of cervical cancer. This is the first guideline on primary prevention of cervical cancer that is tailored to multiple regions of the world with different levels …
Share

13 October
ASCO Issues Global Recommendations to Increase Cervical Cancer Screening

ALEXANDRIA, VA. – The American Society of Clinical Oncology (ASCO) today issued a new global guideline on screening for cervical cancer, one of the leading causes of cancer related death among women worldwide. The guideline provides evidence-based recommendations for screening, follow-up of positive screening results, and treatment of women with …
Share

9 February
ASCO Issues New Guideline on Use of Biomarkers in Early Breast Cancer

ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today issued a new clinical practice guideline for women with early-stage invasive breast cancer and known hormone receptor and human epidermal growth factor 2 (HER2) receptor status. The guideline includes evidence-based recommendations on the appropriate use of breast tumor biomarker tests …
Share

22 January
Celgene Will Present Data from 10 Abraxane-Related Studies at ASCO GI Symposium

SUMMIT, NJ– (Jan. 22, 2016) – Celgene Corporation (NASDAQ: CELG) today announced that 10 studies highlighting combinations that include a foundation of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension)(albumin-bound) and gemcitabine are being presented during the 2016 ASCO Gastrointestinal Cancers Symposium (ASCO GI), establishing the therapy as the foundation for …
Share